Found 20 matching trials
Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC PHASE2 According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Stereotactic Body Radiotherapy for the Treatment of OPD PHASE2 HALT is a phase II, randomised multi-centre study with integrated seamless ...
Show More Location
Institut Gustave Roussy
Learn More & Join Trial
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC N/A The goal of this observational study is to explore the feasibility of stere...
Show More Location
Wuhan Tongji Hospital
Learn More & Join Trial
ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) PHASE2 This is an open-label, prospective single arm Phase II trial that investiga...
Show More Location
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network
Learn More & Join Trial
A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients PHASE2 This study is designed as a phase-II proof of concept trial to investigate ...
Show More Location
Tom Baker Cancer Centre
Learn More & Join Trial
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer PHASE2 This is a randomized, parallel, open-label, multicenter exploratory clinica...
Show More Location
Multiple Locations
Learn More & Join Trial
SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI PHASE2 Despite the impressive response rate to third-generation EGFR-TKIs, resista...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs PHASE2 This study is an open-label, single-arm phase 2 trial to evaluate the effic...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases PHASE3 This is a prospective, multicenter, randomized, controlled clinical study o...
Show More Location
Sun-Yat-Sen university
Learn More & Join Trial
A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC PHASE2 The goal of this clinical trial is to learn if spatially fractionated radio...
Show More Location
2nd Affiliated Hospital, School of Medicine
Learn More & Join Trial